LUSEDRA Drug Patent Profile
✉ Email this page to a colleague
When do Lusedra patents expire, and what generic alternatives are available?
Lusedra is a drug marketed by Eisai Inc and is included in one NDA.
The generic ingredient in LUSEDRA is fospropofol disodium. Additional details are available on the fospropofol disodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LUSEDRA?
- What are the global sales for LUSEDRA?
- What is Average Wholesale Price for LUSEDRA?
Summary for LUSEDRA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| Clinical Trials: | 8 |
| Patent Applications: | 54 |
| DailyMed Link: | LUSEDRA at DailyMed |
Recent Clinical Trials for LUSEDRA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Grace Shih, MD | N/A |
| Mayo Clinic | Phase 4 |
| Eisai Inc. | Phase 1 |
US Patents and Regulatory Information for LUSEDRA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eisai Inc | LUSEDRA | fospropofol disodium | SOLUTION;INTRAVENOUS | 022244-001 | Dec 12, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LUSEDRA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Eisai Inc | LUSEDRA | fospropofol disodium | SOLUTION;INTRAVENOUS | 022244-001 | Dec 12, 2008 | ⤷ Sign Up | ⤷ Sign Up |
| Eisai Inc | LUSEDRA | fospropofol disodium | SOLUTION;INTRAVENOUS | 022244-001 | Dec 12, 2008 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LUSEDRA
See the table below for patents covering LUSEDRA around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Czech Republic | 304020 | Vodorozpustná léciva bránených fenolu (Water-soluble medicaments of hindered phenols) | ⤷ Sign Up |
| Ukraine | 73479 | ВОДОРАСТВОРИМЫЕ ПРОЛЕКАРСТВА БЛОКИРОВАННЫХ СПИРТОВ ИЛИ ФЕНОЛОВ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБ ИХ ПОЛУЧЕНИЯ, ПРОМЕЖУТОЧНОЕ СОЕДИНЕНИЕ (ВАРИАНТЫ) И СПОСОБ ЕГО ПОЛУЧЕНИЯ (ВАРИАНТЫ);ВОДОРОЗЧИННІ ПРОЛІКИ БЛОКОВАНИХ СПИРТІВ ЧИ ФЕНОЛІВ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ, СПОСІБ ЇХ ОДЕРЖАННЯ, ПРОМІЖНА СПОЛУКА (ВАРІАНТИ) ТА СПОСІБ ЇЇ ОДЕРЖАННЯ (ВАРІАНТИ) (WATER-SOLUBLE PRODRUGS OF HINDERED ALCOHOLS OR PHENOLS, PHARMACEUTICAL COMPOSITION BASED THEREON, A METHOD FOR THE PREPARATION THEREOF, INTERMEDIARY COMPOUND (VARIANTS), AND A METHOD FOR THE PREPARATION THEREOF ( VARIANTS)) | ⤷ Sign Up |
| Norway | 20010659 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
